GSA Capital Partners LLP Has $99,000 Stock Position in Quantum-Si incorporated (NASDAQ:QSI)

GSA Capital Partners LLP lessened its stake in shares of Quantum-Si incorporated (NASDAQ:QSI) by 38.4% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 112,317 shares of the company’s stock after selling 69,960 shares during the period. GSA Capital Partners LLP’s holdings in Quantum-Si were worth $99,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. increased its position in Quantum-Si by 1.6% in the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after purchasing an additional 82,463 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Quantum-Si by 11.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock valued at $118,000 after acquiring an additional 5,945 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new position in shares of Quantum-Si in the 1st quarter valued at $27,000. Jacobs Levy Equity Management Inc. bought a new stake in shares of Quantum-Si in the 1st quarter valued at about $998,000. Finally, Virtu Financial LLC acquired a new position in Quantum-Si during the first quarter valued at approximately $98,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Price Performance

Shares of NASDAQ QSI opened at $1.37 on Tuesday. The business has a 50-day moving average of $0.88 and a 200-day moving average of $1.07. The stock has a market capitalization of $195.51 million, a price-to-earnings ratio of -2.14 and a beta of 2.89. Quantum-Si incorporated has a fifty-two week low of $0.61 and a fifty-two week high of $2.43.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. HC Wainwright lifted their price objective on Quantum-Si from $4.00 to $5.50 and gave the company a “buy” rating in a report on Thursday, November 21st. Canaccord Genuity Group lowered their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Wednesday, November 13th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.